Investing1 个月
GSK stock under pressure as Guggenheim flags weak pipeline visibility
On Thursday, Guggenheim, a global investment and advisory firm, downgraded pharmaceutical giant GlaxoSmithKline (NYSE:GSK:LN) (NYSE: GSK (LON:GSK)) stock from Buy to Neutral. The change in rating ...